The Myelodysplastic Syndromes Foundation was established by an international group of physicians and researchers to provide an ongoing exchange of information relating to MDS.
A major Foundation effort is our international information network. This network provides patients with referrals to Centers of Excellence, contact names for available clinical trials, sharing of new research and treatment options between physicians, and extension of educational support to physicians, nurses, pharmacists and patients.
In response to the needs expressed by patients, families, and healthcare professionals, we have established patient advocacy groups, research funding, and professional educational initiatives.
Join us for the MDS 2025 Congress in Rotterdam, where you’ll have the opportunity to explore the forefront of Myelodysplastic Syndromes, connect with leading international experts, and gain valuable insights into the latest advances, discoveries, basic and translational research, as well as MDS diagnosis, prognosis, and management.
Mark your calendars and stay tuned for more details as we embark on this exciting journey towards MDS 2025. Together, we can make a difference in the field of Myelodysplastic Syndromes.
